WCPO: UC helps Ohio company win FDA approval for ventilators
P&G employees develop low-cost ventilators with help from UC Biomedical Engineering and UC Health
A Cincinnati company received help from the University of Cincinnati to win federal regulatory approval for a new low-cost ventilator to treat patients with COVID-19, according to WCPO.
WCPO spoke to John Molander, president of Venti-Now, about the project to provide ventilators to hospitals to meet increased demand from the global pandemic.
UC Health and UC's College of Engineering and Applied Science helped provide medical testing and consultation to win approval from the Food and Drug Administration for the medical device.
The devices will be manufactured in Dayton and southeastern Indiana for distribution around the world.
Venti-Now is composed of former and current employees at Procter & Gamble Co.
How UC is helping battle COVID-19
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
A year after Niger's dramatic coup
July 26, 2024
UC School of Public and International Affairs Associate Professor Alexander Thurston tells ABC News that Mali, Niger and Burkina Faso will face difficult times in the wake of armed conflicts.
Advocates working to get ‘PICS’ named a public health crisis
July 26, 2024
Spectrum News and WVXU highlighted the research partnership of the University of Cincinnati's Rachael Nolan and community advocate Chazidy Robinson who are working to raise awareness and recognition of post-incarceration syndrome.
UC’s commercialization navigator pilots tech transfer at 1819...
July 25, 2024
Housed within the University of Cincinnati’s 1819 Innovation Hub, the Technology Transfer team is vital to safeguarding and managing the intellectual property generated by UC’s researchers. Its mission is to translate UC's cutting-edge innovations into viable technologies by evaluating patentability and commercial viability, ensuring compliance and legal protection, recruiting and maintaining external partners, marketing technologies, negotiating license deals and identifying funding opportunities. This multifaceted approach ensures that groundbreaking discoveries from UC are positioned to reach the market, delivering substantial benefits that impact society.